Trial Profile
A study of Olaparib in pancreatic cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2018
Price :
$35
*
At a glance
- Drugs Olaparib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 21 Feb 2018 New trial record
- 20 Jan 2018 Results presented at the 2018 Gastrointestinal Cancers Symposium